Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06412562

M3VAS Validation in Polish Population

The Maudsley 3-item Visual Analogue Scale (M3VAS) Validation in Polish Population Diagnosed With Major Depressive Episode

Status
Recruiting
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Medical University of Gdansk · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Low mood and anhedonia represent the fundamental symptoms of major depressive disorder (MDD). Nevertheless, there is currently no standardized visual analogue scale available to assess the extent of both symptoms concurrently. The Maudsley 3-item Visual Analogue Scale (M3VAS) is a newly developed tool for participants to self-assess core symptoms of depression: mood quality, pleasure experience (anhedonia), and suicidality. Despite suicidality not being a primary symptom, it is included due to its critical relevance to safety. Participants will be instructed to rate the intensity and frequency of their experiences over the preceding two weeks by marking a 100 mm ungraded line. A researcher will then assign a numerical value based on the mark's position, utilizing the left edge as 0 and the right as 100. The total score range, combining the three symptoms, ranged from 0 (minimum) to 300 (maximum). The M3VAS exhibited good psychometric properties in British population. In this study, the objective is to assess the psychometric properties of the scale within the Polish population diagnosed with major depressive episode within major depressive disorder or bipolar disorder.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTThe Maudsley 3-item Visual Analogue Scale (M3VAS)Patients will be asked to complete The Maudsley 3-item Visual Analogue Scale (M3VAS) and 16-item Quick Inventory of Depressive Symptomatology (QIDS-SR-16).

Timeline

Start date
2024-05-09
Primary completion
2026-09-01
Completion
2026-09-01
First posted
2024-05-14
Last updated
2024-05-14

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT06412562. Inclusion in this directory is not an endorsement.